Combining Antidepressants and Attention Bias Modification in Depression
NCT05503966 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 246
Last updated 2025-03-28
Summary
Background: Major depressive disorder (MDD) is a highly prevalent psychiatric condition associated with significant disability, mortality and economic burden. A large proportion of MDD patients are treated in primary health care (PHC) in the municipalities and represent a challenging group. Attentional Bias Modification (ABM) training in combination with antidepressants (SSRIs) could be an effective treatment. The overall aim of this study is to test the hypothesis that adding an ABM procedure to regular treatment with antidepressants in PHC will result in further improvement of symptoms compared to treatment with antidepressants alone (treatment as usual, TAU) and as compared to an active comparison condition.
Methods: A total of 246 patients with a diagnosis of MDD will be included in this study. The study is a three-armed pragmatic randomized controlled trial comparing the efficacy of ABM as add-on to treatment with antidepressants in primary care (ABM condition) compared to standard antidepressant treatment (TAU condition). In a third group participants will complete the same schedule of intermediate assessments as the ABM condition in addition to TAU , but no ABM, thus controlling for the non-training-specific aspects of the ABM condition (SSRI Active comparison group).
Discussion:
The clinical outcome of this study may help develop easy accessible, low cost treatment of depression in PHC. Moreover, the study aims to broaden our knowledge of optimal treatment for patients with a MDD by providing adjunct treatment to facilitate recovery and long term gain
Conditions
- Depressive Disorder
Interventions
- BEHAVIORAL
-
Attentional Bias Modification
The ABM task is based on a computerized visual Dot-probe task. In the dot-probe task paired stimuli of negative (angry and fearful), positive (happy) or neutral faces are presented, followed by one or two probes (dots) appearing in the spatial location of one of the stimuli. Participants are then required to press one of two buttons as quickly as possible to indicate the number of dots in the probe. In the ABM condition, probes are in the same locus as the more positive/less negative stimuli in 87% of the trials, as opposed to 13% with probes in the same locus as more negative/less positive stimuli. Thus, when completing the ABM, participants should learn to deploy their attention toward the relatively more positive stimuli, and in this way develop a more positive AB.
Sponsors & Collaborators
-
University of Oxford
collaborator OTHER -
University of Oslo
lead OTHER
Principal Investigators
-
Jan I Røssberg, PhD · Universitetet i Oslo/Oslo universitetssykehus
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-22
- Primary Completion
- 2025-03-30
- Completion
- 2025-12-30
Countries
- Norway
Study Locations
More Related Trials
-
Testing the Effectiveness of a Computer-based Program for Depression
NCT01203683 ·Status: COMPLETED ·Phase: PHASE3
-
Attention Bias Modification Treatment for Major Depressive Disorder in Adolescents
NCT02078258 ·Status: COMPLETED ·Phase: NA
-
The Antidepressant Advisor (Study 3): fMRI Study to Predict Treatment Response in Patients With Depression
NCT04342299 ·Status: COMPLETED
-
Cognitive Rehabilitation in Patients With Depression
NCT03338413 ·Status: UNKNOWN ·Phase: NA
-
Tailored Implementation Intervention for Managing Depressed Elderly Patients in Primary Care
NCT01913236 ·Status: COMPLETED ·Phase: NA
-
Patient Dimensions as Predictors of Varied Treatment Responses and Outcomes in Patients With Major Depression
NCT00744406 ·Status: COMPLETED ·Phase: PHASE2
-
The Use of Collaborative Care in General Practice for Elderly Patients With Depression
NCT04078282 ·Status: COMPLETED ·Phase: NA
-
Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis
NCT02330679 ·Status: UNKNOWN ·Phase: PHASE4
-
Antidepressant Adherence for Depressed Adults in Primary Care
NCT06496646 ·Status: RECRUITING ·Phase: NA
-
Action Tendencies and Prognosis in Major Depressive Disorder
NCT04593537 ·Status: COMPLETED
-
Role of Self-focused Attention in Depression
NCT05464550 ·Status: COMPLETED ·Phase: NA
-
Treatment for Depression in the Primary Care Setting
NCT00055328 ·Status: COMPLETED ·Phase: PHASE4
-
Optimizing Outcomes of Treatment-Resistant Depression in Older Adults
NCT02960763 ·Status: COMPLETED ·Phase: PHASE4
-
Medication Treatment for Depression in Nursing Home Residents
NCT00076622 ·Status: COMPLETED
-
Pharmacologic Treatment Augmentation in Chronic Depression
NCT06410599 ·Status: RECRUITING ·Phase: PHASE2
-
Mobile Screening for Major Depressive Disorder in Adults From an Ethnically and Socioeconomically Diverse Population.
NCT05989412 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Study of the Neural Circuits Underlying the Negative Emotional Bias of Depressive Disorders and Their Response to Ketamine
NCT06630065 ·Status: RECRUITING ·Phase: NA
-
Comparing Differing Financial Incentive Structures for Increasing Antidepressant Adherence Among Adults
NCT03441399 ·Status: COMPLETED ·Phase: NA
-
Maintaining Mechanisms of Chronic Depression and Their Changeability
NCT02801513 ·Status: COMPLETED ·Phase: NA
-
Rhythm and Depression
NCT02857036 ·Status: UNKNOWN ·Phase: NA
-
Neurocognitive Enhancement in Major Depressive Disorder
NCT00998569 ·Status: COMPLETED ·Phase: NA
-
Standardized Assessment in Depression Treatment in Routine Psychiatric Services
NCT06332261 ·Status: COMPLETED
-
Depression, Experiential Diversity, and Behavioral Novelty
NCT05767554 ·Status: COMPLETED ·Phase: NA
-
Predictors of Relapse in Major Depressive Disorder (PERFORM-D)
NCT06746155 ·Status: RECRUITING
-
Action-Based Cognitive Remediation to Improve Vocational Outcomes in Depression
NCT02535390 ·Status: COMPLETED ·Phase: NA